Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haoxi Health Technology (HAO) Current Deferred Revenue (2023 - 2025)

Haoxi Health Technology's Current Deferred Revenue history spans 3 years, with the latest figure at $1.2 million for Q4 2025.

  • Quarterly Current Deferred Revenue rose 68.96% to $1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Dec 2025, up 68.96% year-over-year, with the annual reading at $537646.0 for FY2025, 54.63% down from the prior year.
  • Current Deferred Revenue came in at $1.2 million for Q4 2025, up from $537646.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $1.5 million in Q2 2023 to a low of -$488561.0 in Q4 2023.
  • The 3-year median for Current Deferred Revenue is $954840.5 (2024), against an average of $779481.8.
  • Year-over-year, Current Deferred Revenue surged 248.3% in 2024 and then plummeted 54.63% in 2025.
  • Haoxi Health Technology's Current Deferred Revenue stood at -$488561.0 in 2023, then soared by 248.3% to $724551.0 in 2024, then surged by 68.96% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for HAO's Current Deferred Revenue are $1.2 million (Q4 2025), $537646.0 (Q2 2025), and $724551.0 (Q4 2024).